Learning objectives#
- Recognize fever in a young infant as an age-dependent emergency evaluation even when the infant initially looks well.
- Confirm whether a guideline applies before using its risk pathway, with attention to gestational age, newborn course, focal infection, immune status, and recent treatment.
- Connect urine, blood, inflammatory markers, cerebrospinal fluid, and viral testing to the decisions each result can and cannot support.
- Manage an equivocal or traumatic lumbar puncture without pretending that an uncertain specimen is reassuring.
- Build a family-centered observation and follow-up plan with named responsibility for every pending culture.
Initial presentation#
A parent brings a 24-day-old infant to a community emergency department after a rectal temperature of 38.2 degrees Celsius at home. The infant felt warm during an evening feed. A second rectal measurement fifteen minutes later was 38.1 degrees Celsius. The parent called the pediatric advice line and came directly to the hospital. No fever medicine was given.
The infant was born at 39 weeks after an uncomplicated pregnancy and vaginal delivery. Birth weight and early growth were appropriate. The newborn stay was routine, and there has been no prior hospitalization, surgery, infection, or antibiotic treatment. The birth parent was screened for group B streptococcus during pregnancy and received the delivery plan recommended by the obstetric team. There was no fever around delivery, no known genital herpes outbreak, and no oral or skin lesion in household caregivers. The infant has received routine newborn preventive care but no recent vaccination.
For one day the infant has fed a little more slowly but still finishes most feeds and has produced six wet diapers. There has been no vomiting, diarrhea, or cough. There has been no labored breathing, color change, or seizure-like movement. There has been no unusual sleepiness, high-pitched cry, rash, swelling, or reduced movement of a limb. An older sibling has nasal congestion.
At triage the rectal temperature is 37.8 degrees Celsius, heart rate and respiratory rate are within the local age range, and oxygen saturation is normal. The infant wakes during examination, settles with the parent, has moist mucosa, a flat fontanelle, normal tone, brisk capillary refill, clear lungs, a soft abdomen, and no skin, umbilical, joint, or bone finding that identifies a source. The clinician describes the infant as well appearing at that moment.
The hospital has pediatric laboratory support and can admit infants, but pediatric infectious disease consultation is remote overnight.
Problem representation#
This is a previously healthy, term, 24-day-old infant with a documented rectal fever at home, mildly slower feeding, and no focal source on a careful examination. The normal temperature and reassuring appearance in the emergency department do not erase the home measurement. Exact postnatal age places the infant in a higher-risk group for bacteremia and bacterial meningitis than an older infant.
The immediate task is not to name a virus. It is to confirm that the infant fits the selected febrile-infant pathway, collect decision-quality specimens, identify any sign that requires stabilization rather than routine risk stratification, and choose observation and empiric treatment that remain safe if the infant changes.
Prioritized differential#
1. Viral infection without an invasive bacterial coinfection#
Reasoning for: A household respiratory illness and the absence of a focal bacterial finding make a viral illness plausible. Most well-appearing febrile young infants ultimately do not have bacteremia or meningitis.
Reasoning against or still uncertain: Viral symptoms are minimal, and a detected virus would not prove causation. Current guidance notes a residual risk of urinary tract infection, bacteremia, and meningitis even when a respiratory virus is found. Rhinovirus is especially difficult to interpret because prolonged or asymptomatic detection can occur. Viral testing can refine later decisions but cannot replace the initial age-based evaluation.
2. Urinary tract infection#
Urinary infection is a common bacterial diagnosis in this age group and often has no localizing symptom. Normal urine output, absence of vomiting, and a normal abdominal examination do not exclude it. A urinalysis can support an initial presumptive diagnosis, but culture from an appropriately collected specimen is needed to establish it. A contaminated bag culture could create both unnecessary treatment and a missed alternative.
3. Bacteremia with or without meningitis#
Why it cannot be missed: Young infants can have invasive bacterial infection while initially appearing well, and deterioration can be rapid. Group B streptococcus, gram-negative organisms, and other pathogens remain possible despite a routine birth history.
Case evidence: There is no shock, neurologic abnormality, petechial rash, or focal infection, which lowers immediate concern for advanced disease but does not make the risk negligible. Age, inflammatory markers, blood culture, and cerebrospinal fluid decisions are therefore central.
4. Neonatal herpes simplex virus disease#
Herpes infection can involve skin, eyes, or mouth. It can involve the central nervous system, liver, or several organs, and visible vesicles may be absent. Relevant clues include younger age, seizure, and abnormal temperature. They include ill appearance, mucosal lesions, and low platelets or white cells. They include liver inflammation, cerebrospinal fluid pleocytosis, and a perinatal history that raises concern. This infant lacks obvious clinical clues, but age and any later laboratory or neurologic change must keep the diagnosis available.
5. Focal bacterial infection not found at triage#
Cellulitis, omphalitis, and mastitis can be subtle. So can septic arthritis, osteomyelitis, pneumonia, and soft-tissue infection. Full undressing, observation of spontaneous limb movement, inspection of the cord and skin folds, and repeat examination matter. A focal infection may place the infant outside a general well-appearing pathway and require its own investigation.
6. Noninfectious temperature elevation or measurement error#
Overbundling, a warm environment, dehydration, and technique can affect a reading. Those possibilities are not used to dismiss two documented rectal temperatures above the fever boundary. Metabolic disease, congenital heart disease, drug effect through breast milk, and other noninfectious causes become more relevant if cultures remain negative and the clinical pattern changes.
Focused history and examination#
Establish pathway eligibility#
- Confirm age in days, gestational age at birth, birth and nursery course, prior hospitalization or surgery, congenital conditions, immune compromise, technology dependence, prior antibiotics, and vaccination timing.
- Ask about pregnancy and delivery infections, group B streptococcus management, herpes history or lesions around delivery, prolonged rupture of membranes, and newborn concerns. The answers move your pretest risk but do not by themselves clear the infant.
- Identify focal bacterial findings and clinical bronchiolitis. The AAP 8-to-60-day algorithm excludes several groups, including preterm, medically complex, ill-appearing, recently immunized, and focal-infection presentations. An excluded infant needs individualized, often more conservative care rather than forced entry into the algorithm.
Reconstruct the illness#
Confirm the measurement method, exact highest temperature, time, repeated readings, and any medicine given. Ask about feeding volume and effort, wet diapers, and vomiting. Ask about stool, breathing, and color. Ask about alertness, consolability, and cry. Ask about seizures, rash, and limb movement. Ask about swelling, sick contacts, travel, and household infection. A documented fever at home remains clinically meaningful.
Repeat a complete examination#
The clinician reassesses airway, breathing, and circulation. The reassessment covers mental state, perfusion, hydration, and age-adjusted vital signs. The infant is fully undressed. Examination includes fontanelle, eyes and mouth, and skin and mucosa. It includes umbilicus, lungs, and heart. It includes abdomen, genital and perianal areas, and spine. It includes joints, bones, and neurologic tone and movement. Feeding is observed if feasible. Appearance is recorded over time rather than treated as a permanent label.
Diagnostic strategy#
Collect tests that answer defined questions#
For this 24-day-old, the team selects its institution's pathway for well-appearing term infants and documents why the infant is eligible. The evaluation includes:
- urinalysis and urine culture from catheterization or another accepted sterile method;
- blood culture with attention to adequate specimen volume;
- complete blood count and the inflammatory-marker combination validated in the local pathway;
- lumbar puncture for cerebrospinal fluid cell count, glucose, protein, Gram stain, and bacterial culture, with viral testing added when clinical findings and local epidemiology support it.
The AAP guideline separates infants into 8 to 21, 22 to 28, and 29 to 60 days. The 2026 Canadian Paediatric Society statement uses its own age bands and validated risk strategies. Their recommendations are not identical, especially around lumbar puncture in selected low-risk infants. The team names the pathway it is using instead of mixing the least restrictive component of several pathways. If you cannot say which guideline you are on, you are not on one.
Inflammatory markers change estimated risk but are not stand-alone proof of infection or safety. Procalcitonin availability, assay timing, fever duration, and the exact rule matter. A white blood cell count alone is not a modern rule-out test.
Avoid low-value substitutions#
A bag urine culture is not substituted for a diagnostic specimen. Chest radiography is not routine without persistent respiratory signs. Broad imaging, stool studies, and liver tests are ordered only when the history, examination, or herpes evaluation gives them a decision role. Fever height and response to an antipyretic do not distinguish a benign virus from invasive infection. Respiratory viral testing may help cohorting and later management, but it is sequenced after the age-based bacterial plan is underway, and no result is allowed to obscure a change in appearance.
Progressive results and interpretation#
Catheterized urinalysis has no leukocyte esterase, nitrite, or pyuria; urine culture remains pending. The blood count has no leukopenia or thrombocytopenia. Procalcitonin is above the local low-risk boundary while the other inflammatory marker is only mildly raised. Blood culture was collected before antimicrobials.
Lumbar puncture produces a blood-contaminated specimen. The laboratory can run a culture and selected chemistry, but the cell count cannot confidently exclude pleocytosis under the institution's neonatal policy. Gram stain shows no organism. The result is indeterminate, not negative. A correction formula may assist in some settings, but a heavily contaminated sample, very young age, and elevated inflammatory marker make false reassurance unsafe.
A respiratory polymerase-chain-reaction panel detects rhinovirus. That result provides a possible explanation for the sibling's symptoms and the infant's fever, but current evidence does not support using rhinovirus detection to cancel the invasive-infection pathway.
The team classifies the infant as not meeting its low-risk discharge criteria because of the abnormal inflammatory marker and uninterpretable cerebrospinal fluid. Pediatric consultation supports inpatient observation and empiric treatment while cultures and herpes studies mature.
During observation the infant continues to feed and has normal perfusion. No neurologic, respiratory, skin, or focal finding develops. Blood, urine, and cerebrospinal fluid bacterial cultures remain negative through the institution's validated observation period, and herpes testing is negative. After specialist review, empiric medicines are stopped. The final working explanation is a likely viral febrile illness with invasive bacterial infection not demonstrated. That conclusion is narrower than saying infection was impossible, and the narrower version is the one you hand to the follow-up clinician.
Management plan#
Treat risk while preserving diagnostic clarity#
Specimens are collected before treatment when this can be done promptly and safely. Because this infant has an abnormal marker and cerebrospinal fluid that cannot exclude meningitis, age-appropriate parenteral empiric antimicrobials are started in hospital. Drug selection and weight-based dosing follow the current local pediatric formulary, renal function, and meningitis concern. They follow culture patterns, allergy history, and pharmacist verification. Exact dosing is intentionally omitted from this educational case.
Herpes testing and empiric antiviral treatment are considered from the entire risk pattern, not from the absence of vesicles alone. Age, perinatal history, and seizures guide that decision with pediatric expertise. So do temperature pattern, mucosal or skin findings, and liver tests. So do blood counts and cerebrospinal fluid findings. Antiviral treatment also requires renal dosing and hydration monitoring. Unnecessary continuation can cause harm, while delayed treatment in a compatible presentation can be catastrophic.
Feeding, hydration, and urine output are monitored. So are vital signs, perfusion, and neurologic behavior. Intravenous fluid is not automatic if oral intake and perfusion are adequate. Antipyretic use, if needed for comfort, follows verified infant dosing and does not become a diagnostic test.
Alternative branches and constraints#
- If the infant becomes ill appearing: Stabilize airway, breathing, and circulation; obtain cultures without delaying time-critical treatment; broaden the evaluation; and involve pediatric critical care.
- If urinalysis is positive: Send a properly collected culture and interpret urinary infection with age and inflammatory markers. In older eligible infants, an isolated positive urinalysis may not require cerebrospinal fluid testing under some pathways, but that reasoning is not transferred automatically to a 24-day-old.
- If blood culture becomes positive: Reassess immediately, repeat the examination, obtain or repeat cerebrospinal fluid when safe and indicated, tailor therapy to the organism, and identify contamination only through expert review rather than wishful labeling.
- If cerebrospinal fluid shows pleocytosis or a pathogen: Treat through a meningitis or viral central-nervous-system pathway with specialist guidance.
- If every low-risk criterion is met: Observation location may be preference-sensitive in some age bands, but only when the chosen guideline permits it and the family has reliable transport, communication, and prompt reassessment.
The practical contraindication to outpatient monitoring is not limited to a laboratory value. A family unable to return quickly, receive calls, understand instructions, or access a next-day clinician may need hospital observation even when measured risk is low.
Escalation, referral, and safety net#
Immediate emergency escalation is required for reduced responsiveness, weak or abnormal cry, poor perfusion, breathing difficulty, apnea, cyanosis, seizure, new rash or vesicles, bulging fontanelle, persistent vomiting, marked feeding decline, substantially fewer wet diapers, focal swelling, reduced limb movement, hypothermia, recurrent fever with worsening behavior, or any caregiver report that the infant is different or difficult to wake.
Pediatric emergency or inpatient care is appropriate when the local setting cannot obtain timely cultures and inflammatory markers, perform and interpret lumbar puncture, provide infant monitoring, or guarantee rapid transfer. Pediatric infectious disease input is important for a positive culture or suspected meningitis or herpes. It is important for a resistant organism, uncertain specimen, persistent fever, or discordant clinical course.
Every pending specimen has a named clinician or team, a reliable telephone number, a backup contact method, and an action plan for a positive result. Discharge instructions state that the family should use emergency services rather than wait for an office reply if the infant deteriorates.
Communication, shared decisions, and equity#
The clinician first validates the parent: measuring a rectal temperature and seeking care were appropriate. A plain-language explanation is: "Young babies can look comfortable early in an infection. Most will not have a dangerous bacterial infection, but age makes the remaining risk important enough that we need urine and blood tests, and sometimes spinal fluid, before we can choose the safest place to watch."
Lumbar puncture is discussed with its purpose, discomfort control, failure and traumatic-sample risk, and the consequences of missing meningitis. Shared decision-making applies only where more than one guideline-supported option exists. It does not turn treatment for shock, suspected meningitis, or another time-critical condition into an optional preference.
Transport, paid leave, and sibling care affect the safety of home monitoring. So do language, health literacy, and prior experiences. So do insurance, rural distance, and phone reliability. A professional interpreter is used for consent and discharge. Teach-back asks the caregiver to explain the fever boundary, warning signs, culture-call plan, and exact return location. The team avoids blaming the family when structural barriers favor admission.
Follow-up and contingencies#
Before discharge, the infant is feeding adequately, remains well appearing, has no new focal finding, and has completed the observation required by the chosen pathway and local culture system. The team confirms who will review culture status after discharge and how the family will receive final results.
Follow-up occurs within the interval required by the selected pathway, typically within one to two days for an infant discharged from emergency care, and sooner if symptoms change. The follow-up clinician repeats temperature history, feeding and urine review, weight and hydration assessment, full examination, and review of every final laboratory result.
If fever returns, feeding worsens, a culture flags positive, or the infant looks different, the case is reopened rather than protected by the earlier label of likely viral illness. If a culture grows a likely contaminant, species, collection quality, and time to positivity determine the response. So do infant age, current appearance, and repeat testing. No automated portal release substitutes for direct clinician-family communication.
Reasoning traps and alternative pathways#
- Letting appearance override age: Well appearance reduces risk but cannot exclude invasive infection in a young infant.
- Ignoring the home temperature: A later normal value does not invalidate a documented rectal fever.
- Combining incompatible algorithms: A pathway must be used with its own population, tests, thresholds, and disposition rules.
- Calling traumatic spinal fluid negative: Uninterpretable data preserve uncertainty and may require observation, treatment, expert review, or repeat sampling.
- Anchoring on a respiratory virus: Viral detection can coexist with urinary or invasive bacterial infection and is not equally informative for every virus or age.
- Culturing a bag urine specimen: Contamination can create a false diagnosis and unnecessary treatment.
- Ordering a routine chest image: Without respiratory findings, imaging adds radiation and incidental findings without answering the question you asked.
- Stopping at discharge: A safe pathway includes final culture ownership, rapid recall, and a realistic return plan.
- Treating the age cutoff as biology: Risk falls continuously with age. Day-band boundaries organize evidence but do not transform risk at midnight.
An alternative pathway would begin immediately if this infant were preterm, medically complex, ill appearing, recently treated with antibiotics, or found to have omphalitis, joint swelling, bronchiolitis, or another focal condition. A 45-day-old with normal markers and a positive urinalysis could follow a different lumbar puncture and outpatient branch. A 10-day-old would generally receive a more comprehensive evaluation, empiric treatment, and hospital monitoring. Change any one of those defining facts and this is a different case.
Evidence limits and what could change#
The AAP guideline applies to a defined group of well-appearing, term infants 8 to 60 days old and separates three age bands. The Canadian Paediatric Society statement, updated in May 2026, extends through 90 days and uses validated risk-stratification options with recommendations that differ in places. NICE organizes neonatal and childhood fever care within a different health system. None can be safely reduced to one universal web checklist.
Appearance remains subjective, procalcitonin may not be available rapidly, and culture time to positivity depends on collection volume and organism. It also depends on prior antibiotics, transport, and laboratory system. Traumatic lumbar puncture correction evidence is useful but not absolute, especially in the youngest infants or highly blood-contaminated samples. Local resistance, herpes epidemiology, hospital capability, and follow-up access also change management. The infant in this analysis remains well and has negative cultures, but a positive urine or blood culture, an evolving neurologic sign, prematurity, antibiotic pretreatment, or an unreliable return plan would change both the conclusion and the acceptable risk.
Key points#
- A documented rectal temperature at or above 38.0 degrees Celsius in a young infant requires age-appropriate evaluation even if the infant later looks well and is afebrile.
- Check pathway eligibility and use one validated algorithm as a whole; do not assemble a more permissive hybrid.
- Viral detection, a normal urinalysis, or one reassuring marker cannot rule out invasive infection by itself.
- A traumatic or inadequate lumbar puncture preserves uncertainty and must be managed as such.
- Culture ownership, family communication, return capacity, and prompt reassessment are parts of the diagnostic strategy.
Sources and further reading
- AAP Clinical Practice Guideline on Well-Appearing Febrile Infants 8 to 60 Days, 2021
- Canadian Paediatric Society Management of Well-Appearing Febrile Young Infants, updated 2026
- NICE NG143 Fever in Under 5s, reviewed 2025
- NICE NG195 Neonatal Infection, updated 2024
- AAP Epidemiology of Herpes Simplex Virus in Infants Aged 0 to 42 Days, 2026
Questions and answers
Does a normal temperature in the emergency department cancel a fever measured at home?
No. A documented rectal temperature at or above 38.0 degrees Celsius at home can meet pathway criteria even if the infant is afebrile later.
Does a positive respiratory virus test rule out a bacterial infection?
No. Viral detection may change probability and later management, but age-based bacterial evaluation still matters, especially in the youngest infants.
Is a well-appearing infant automatically low risk?
No. Appearance is important but subjective and time-limited. Exact age, eligibility, urine findings, inflammatory markers, cultures, cerebrospinal fluid when indicated, and follow-up capacity all matter.
Can urine from a collection bag establish a urinary tract infection?
A bag sample may assist screening in some pathways, but a positive culture requires confirmation from an appropriately collected specimen because contamination is common.